BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 19217304)

  • 21. PTP1B inhibitors: synthesis and evaluation of difluoro-methylenephosphonate bioisosteres on a sulfonamide scaffold.
    Holmes CP; Li X; Pan Y; Xu C; Bhandari A; Moody CM; Miguel JA; Ferla SW; De Francisco MN; Frederick BT; Zhou S; Macher N; Jang L; Irvine JD; Grove JR
    Bioorg Med Chem Lett; 2008 Apr; 18(8):2719-24. PubMed ID: 18372175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of miltirone analogues as inhibitors of Cdc25 phosphatases.
    Huang W; Li J; Zhang W; Zhou Y; Xie C; Luo Y; Li Y; Wang J; Li J; Lu W
    Bioorg Med Chem Lett; 2006 Apr; 16(7):1905-8. PubMed ID: 16434190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A gatekeeper residue for inhibitor sensitization of protein tyrosine phosphatases.
    Bishop AC; Blair ER
    Bioorg Med Chem Lett; 2006 Aug; 16(15):4002-6. PubMed ID: 16716588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PTP1B as a drug target: recent developments in PTP1B inhibitor discovery.
    Zhang S; Zhang ZY
    Drug Discov Today; 2007 May; 12(9-10):373-81. PubMed ID: 17467573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigations of linker structure on the potency of a series of bidentate protein tyrosine phosphatase inhibitors.
    Xie J; Seto CT
    Bioorg Med Chem; 2005 Apr; 13(8):2981-91. PubMed ID: 15781408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure-based virtual screening approach to identify novel classes of PTP1B inhibitors.
    Park H; Bhattarai BR; Ham SW; Cho H
    Eur J Med Chem; 2009 Aug; 44(8):3280-4. PubMed ID: 19269068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and synthesis of new potent PTP1B inhibitors with the skeleton of 2-substituted imino-3-substituted-5-heteroarylidene-1,3-thiazolidine-4-one: Part I.
    Meng G; Zheng M; Wang M; Tong J; Ge W; Zhang J; Zheng A; Li J; Gao L; Li J
    Eur J Med Chem; 2016 Oct; 122():756-769. PubMed ID: 27526040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies of the mechanism of selectivity of protein tyrosine phosphatase 1B (PTP1B) bidentate inhibitors using molecular dynamics simulations and free energy calculations.
    Fang L; Zhang H; Cui W; Ji M
    J Chem Inf Model; 2008 Oct; 48(10):2030-41. PubMed ID: 18831546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pyrrolo[2,3-c]azepine derivatives: a new class of potent protein tyrosine phosphatase 1B inhibitors.
    Xie J; Tian J; Su L; Huang M; Zhu X; Ye F; Wan Y
    Bioorg Med Chem Lett; 2011 Jul; 21(14):4306-9. PubMed ID: 21696953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of functionalized acetophenones as protein tyrosine phosphatase 1B inhibitors.
    Dixit M; Tripathi BK; Srivastava AK; Goel A
    Bioorg Med Chem Lett; 2005 Jul; 15(14):3394-7. PubMed ID: 15951172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and biological evaluation of heterocyclic ring-substituted maslinic acid derivatives as novel inhibitors of protein tyrosine phosphatase 1B.
    Qiu WW; Shen Q; Yang F; Wang B; Zou H; Li JY; Li J; Tang J
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6618-22. PubMed ID: 19846303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis, in vitro and computational studies of protein tyrosine phosphatase 1B inhibition of a small library of 2-arylsulfonylaminobenzothiazoles with antihyperglycemic activity.
    Navarrete-Vazquez G; Paoli P; León-Rivera I; Villalobos-Molina R; Medina-Franco JL; Ortiz-Andrade R; Estrada-Soto S; Camici G; Diaz-Coutiño D; Gallardo-Ortiz I; Martinez-Mayorga K; Moreno-Díaz H
    Bioorg Med Chem; 2009 May; 17(9):3332-41. PubMed ID: 19362487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low molecular weight protein tyrosine phosphatase and caveolin-1: interaction and isoenzyme-dependent regulation.
    Caselli A; Taddei ML; Bini C; Paoli P; Camici G; Manao G; Cirri P; Ramponi G
    Biochemistry; 2007 May; 46(21):6383-92. PubMed ID: 17469800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Design, synthesis and evaluation of malonic acid-based PTP1B inhibitors].
    Du X; Zhang SE; Liu JZ; Nie FL; Ye F; Tian JY; Xiao ZY
    Yao Xue Xue Bao; 2012 Mar; 47(3):367-73. PubMed ID: 22645761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation of the protein tyrosine phosphatase 1B inhibitory metabolite from the marine-derived fungus Cosmospora sp. SF-5060.
    Seo C; Sohn JH; Oh H; Kim BY; Ahn JS
    Bioorg Med Chem Lett; 2009 Nov; 19(21):6095-7. PubMed ID: 19782562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gold(I)-mediated inhibition of protein tyrosine phosphatases: a detailed in vitro and cellular study.
    Krishnamurthy D; Karver MR; Fiorillo E; Orrú V; Stanford SM; Bottini N; Barrios AM
    J Med Chem; 2008 Aug; 51(15):4790-5. PubMed ID: 18605719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thiazolidinedione derivatives as PTP1B inhibitors with antihyperglycemic and antiobesity effects.
    Bhattarai BR; Kafle B; Hwang JS; Khadka D; Lee SM; Kang JS; Ham SW; Han IO; Park H; Cho H
    Bioorg Med Chem Lett; 2009 Nov; 19(21):6161-5. PubMed ID: 19783142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of Yersinia protein tyrosine phosphatase by phosphonate derivatives of calixarenes.
    Vovk AI; Kononets LA; Tanchuk VY; Cherenok SO; Drapailo AB; Kalchenko VI; Kukhar VP
    Bioorg Med Chem Lett; 2010 Jan; 20(2):483-7. PubMed ID: 20015646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of protein tyrosine phosphatases PTP1B and CD45 by sulfotyrosyl peptides.
    Desmarais S; Jia Z; Ramachandran C
    Arch Biochem Biophys; 1998 Jun; 354(2):225-31. PubMed ID: 9637730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parallel synthesis of a library of bidentate protein tyrosine phosphatase inhibitors based on the alpha-ketoacid motif.
    Chen YT; Seto CT
    Bioorg Med Chem; 2004 Jun; 12(12):3289-98. PubMed ID: 15158797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.